SHARE:  

Week of August 1, 2023 | Vol. 12, Issue 30

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

Investment Banking

Strategic Capital

Research


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Senior Managing Director, Head of Investment Banking

jjohnson@bourne-partners.com

Industry Snapshot

Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

595330 image
1686840562811 image

NACDS TSE

August 12-14, 2023 - San Diego, CA

Contract Pharma 2023

September 5-8, 2023 - New Brunswick, NJ

Bourne Partners Annual CEO Summit 2023

Invitation Only

October 4, 2023 - Charlotte, NC

CPHI Barcelona

October 24-26, 2023 - Barcelona, Spain

Supply Side West 2023

October 23-27, 2023 - Las Vegas, NV

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A Transactions

Pharma & Biotech

14 transactions totaling $8.6 billion


Supplies, Equipment & Services

22 transactions totaling $1.2 billion


Healthcare Facilities & Distributors

2 transactions


Healthcare IT & Managed Care

5 transactions

Private Placements

Pharma & Biotech

21 transactions totaling $515 million


Supplies, Equipment & Services

9 transactions totaling $272 million


Healthcare Facilities & Distributors

7 transactions totaling $164 million


Healthcare IT & Managed Care

15 transactions totaling $106 million

Public Offerings

Pharma & Biotech

8 transactions totaling $387 million


Supplies, Equipment & Services

9 transactions totaling $81 million


Healthcare Facilities & Distributors

0 transactions


Healthcare IT & Managed Care

4 transactions totaling $19 million

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Biostorage Services Market Insight

July 2023

Market Insight Capital Markets Update

October 2022

Pharma Sector Snapshot 1H 2022

August 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Matador

Pharma | Sell-Side

Acquisition opportunity of two sterile injectable ANDAs


Project Panther

Pharma Services | Sell-Side

Acquisition opportunity of OTC and personal care CDMO


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Curia expands biologics capabilities with access to Touchlight’s doggybone DNA

Globe Newswire - Jul 24, 2023

Thompson Street Capital Partner’s Vector Laboratories Acquires Quanta BioDesign

Business Wire - Jul 25, 2023

Catalyst Clinical acquires Genpro Research to expand global presence

Fierce Biotech - Jul 26, 2023

Exclusive: Cell therapy CDMO Kincell launches, and the spinout is valued at $66M, with CEO looking for carve-outs

Endpoints News - Jul 26, 2023

Fortrea inks deal with Australia's Incannex for sleep apnea drug trial

Fierce Biotech - Jul 27, 2023

Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM197

PR Newswire - Jul 27, 2023

Peters, Blackburn, and Brown Introduce Bipartisan Bill to Fight Drug Shortages and Increase Available Supply of Critical Medications and Their Key Ingredients

Homeland Security & Governmental Affairs - Jul 27, 2023

Worldwide Clinical partners with Cybin for psychedelic-based treatments

Fierce Biotech - Jul 27, 2023

Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas' Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization

PR Newswire - Jul 27, 2023

Private equity deals in pharmaceutical increased in Q2 2023

Pharmaceutical Technology - Jul 28, 2023

Bernie Sanders plans more drug price caps as big pharma fights back

Pharmaceutical Technology - Jul 28, 2023

Rx Machina: How AI is transforming pharma sales

Pharmaceutical Technology - Jul 31, 2023

TANNER NEWS

Linkedin  
Website-images-1578-x-979-24-1024x635 image

Overcoming challenges with medical product classification in Latin America


Classification of medical products can vary greatly from one country to another, especially in Latin America. To sell products in specific markets, product owners must understand where any differences lie in how they are categorized. Learn more about navigating these market complexities.